These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30284731)

  • 1. Micronuclei frequency in urothelial cells of bladder cancer patients, as a biomarker of prognosis.
    Espinoza F; Cecchini L; Morote J; Marcos R; Pastor S
    Environ Mol Mutagen; 2019 Mar; 60(2):168-173. PubMed ID: 30284731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer.
    Todenhöfer T; Hennenlotter J; Guttenberg P; Mohrhardt S; Kuehs U; Esser M; Aufderklamm S; Bier S; Harland N; Rausch S; Gakis G; Stenzl A; Schwentner C
    BMC Cancer; 2015 Mar; 15():155. PubMed ID: 25884545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic instability persists in non-neoplastic urothelial cells from patients with a history of urothelial cell carcinoma.
    de Castro Marcondes JP; de Oliveira ML; Gontijo AM; de Camargo JL; Salvadori DM
    PLoS One; 2014; 9(1):e86162. PubMed ID: 24465937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancer.
    Pardini B; Viberti C; Naccarati A; Allione A; Oderda M; Critelli R; Preto M; Zijno A; Cucchiarale G; Gontero P; Vineis P; Sacerdote C; Matullo G
    Br J Cancer; 2017 Jan; 116(2):202-210. PubMed ID: 27959887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary markers in the everyday diagnosis of bladder cancer.
    Dal Moro F; Valotto C; Guttilla A; Zattoni F
    Urologia; 2013; 80(4):265-75. PubMed ID: 24419920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of semaphorin 3A in patients with urothelial cancer.
    Vadasz Z; Rubinstein J; Bejar J; Sheffer H; Halachmi S
    Urol Oncol; 2018 Apr; 36(4):161.e1-161.e6. PubMed ID: 29288007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study.
    Frantzi M; van Kessel KE; Zwarthoff EC; Marquez M; Rava M; Malats N; Merseburger AS; Katafigiotis I; Stravodimos K; Mullen W; Zoidakis J; Makridakis M; Pejchinovski M; Critselis E; Lichtinghagen R; Brand K; Dakna M; Roubelakis MG; Theodorescu D; Vlahou A; Mischak H; Anagnou NP
    Clin Cancer Res; 2016 Aug; 22(16):4077-86. PubMed ID: 27026199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.
    Pichler R; Fritz J; Tulchiner G; Klinglmair G; Soleiman A; Horninger W; Klocker H; Heidegger I
    BJU Int; 2018 Jan; 121(1):29-37. PubMed ID: 28941000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The frequencies of micronuclei, nucleoplasmic bridges and nuclear buds as biomarkers of genomic instability in patients with urothelial cell carcinoma.
    Podrimaj-Bytyqi A; Borovečki A; Selimi Q; Manxhuka-Kerliu S; Gashi G; Elezaj IR
    Sci Rep; 2018 Dec; 8(1):17873. PubMed ID: 30552338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water.
    Moore LE; Smith AH; Hopenhayn-Rich C; Biggs ML; Kalman DA; Smith MT
    Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):31-6. PubMed ID: 8993795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer.
    Leyh H; Marberger M; Conort P; Sternberg C; Pansadoro V; Pagano F; Bassi P; Boccon-Gibod L; Ravery V; Treiber U; Ishak L
    Eur Urol; 1999 Jan; 35(1):52-6. PubMed ID: 9933795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer.
    D Elia C; Pycha A; Folchini DM; Mian C; Hanspeter E; Schwienbacher C; Vjaters E; Pycha A; Trenti E
    J Clin Pathol; 2019 Feb; 72(2):140-144. PubMed ID: 30355587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micronucleus in atypical urothelial cells.
    Arora SK; Dey P; Saikia UN
    Diagn Cytopathol; 2010 Nov; 38(11):811-3. PubMed ID: 20049965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical performance and utility of a NNMT-based urine test for bladder cancer.
    Pozzi V; Di Ruscio G; Sartini D; Campagna R; Seta R; Fulvi P; Vici A; Milanese G; Brandoni G; Galosi AB; Montironi R; Cecati M; Emanuelli M
    Int J Biol Markers; 2018 Jan; 33(1):94-101. PubMed ID: 29148015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project.
    Schmitz-Dräger C; Bonberg N; Pesch B; Todenhöfer T; Sahin S; Behrens T; Brüning T; Schmitz-Dräger BJ
    Urol Oncol; 2016 Oct; 34(10):452-9. PubMed ID: 27381893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing urothelial cell preparation for the human urinary micronucleus assay.
    Fortin F; Anghel T; Brochu P; Lemieux N
    Toxicol In Vitro; 2010 Sep; 24(6):1821-7. PubMed ID: 20580813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
    Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
    Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis.
    Eissa S; Matboli M; Essawy NO; Kotb YM
    Tumour Biol; 2015 Dec; 36(12):9545-52. PubMed ID: 26138586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies.
    Raitanen MP;
    World J Urol; 2008 Feb; 26(1):45-50. PubMed ID: 18180926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of variant microscopic interpretation of the uCyt+ immunocytological urine test for the detection of bladder cancer.
    Deininger S; Todenhöfer T; Hennenlotter J; Gerber V; Schwarz J; Bedke J; Schwentner C; Stenzl A; Rausch S
    Diagn Cytopathol; 2018 Feb; 46(2):111-116. PubMed ID: 29115014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.